A meta-analysis of the efficacy and safety of HDAC inhibitors combined with exemestane in the treatment of HR+/HER2- advanced Metastatic breast cancer
LI Shuo, YANG Zhi-xuan, GONG Wen-lin, QIE Hong-xin, WANG Pei-yuan, GAO Xiao-nan, GAO Jing-lin, WANG Ming-xia
Chinese Journal of New Drugs . 2026, (18): 1999 -2008 .  DOI: 10.20251/j.cnki.1003-3734.2026.18.012